Skip to main content
Clinical Trials/ACTRN12622001500741
ACTRN12622001500741
Not yet recruiting
未知

se of mobile phone TEXT messages to increase the adherence of SGLT2 Inhibitors: a MULti-country Effectiveness-Implementation trial (TEXT-STIMULI)

The University of Sydney0 sites476 target enrollmentNovember 30, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
The University of Sydney
Enrollment
476
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 30, 2022
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • An indication for SGLT2 Inhibitor (as per Australian and Canadian guidelines at time of assessment).
  • Receiving a first, and ongoing, prescription for an SGLT2 Inhibitor.
  • Access to an operational smart mobile telephone that can send and receive text messages, open multimedia files, and access the Internet.
  • Sufficient English language proficiency to read and understand text messages on a mobile telephone.
  • Willing and able to perform trial related procedures.

Exclusion Criteria

  • Life expectancy less than 12 months.
  • Already prescribed an SGLT2i more than 3 months prior to assessment.
  • Diagnosed with Type 1 diabetes mellitus or gestational diabetes.

Outcomes

Primary Outcomes

Not specified

Similar Trials